Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Neuronetics (STIM) EBIT Margin (2017 - 2025)

Neuronetics (STIM) has disclosed EBIT Margin for 9 consecutive years, with 12.07% as the latest value for Q4 2025.

  • Quarterly EBIT Margin rose 3893.0% to 12.07% in Q4 2025 from the year-ago period, while the trailing twelve-month figure was 21.08% through Dec 2025, up 2508.0% year-over-year, with the annual reading at 21.08% for FY2025, 2508.0% up from the prior year.
  • EBIT Margin for Q4 2025 was 12.07% at Neuronetics, up from 19.63% in the prior quarter.
  • The five-year high for EBIT Margin was 12.07% in Q4 2025, with the low at 71.47% in Q1 2022.
  • Average EBIT Margin over 5 years is 43.38%, with a median of 45.59% recorded in 2021.
  • The sharpest move saw EBIT Margin crashed -3257bps in 2021, then skyrocketed 3893bps in 2025.
  • Over 5 years, EBIT Margin stood at 45.99% in 2021, then grew by 8bps to 42.46% in 2022, then soared by 49bps to 21.79% in 2023, then tumbled by -134bps to 51.0% in 2024, then soared by 76bps to 12.07% in 2025.
  • According to Business Quant data, EBIT Margin over the past three periods came in at 12.07%, 19.63%, and 21.15% for Q4 2025, Q3 2025, and Q2 2025 respectively.